These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 23570222)
1. [Issues in cancer pharmacogenomics]. Korean J Hepatol; 2005; 11 Suppl 1():19-31. PubMed ID: 23570222 [No Abstract] [Full Text] [Related]
2. Pharmacogenomics: from bedside to clinical practice. Marsh S; McLeod HL Hum Mol Genet; 2006 Apr; 15 Spec No 1():R89-93. PubMed ID: 16651374 [TBL] [Abstract][Full Text] [Related]
3. Cancer pharmacogenetics. Marsh S Methods Mol Biol; 2008; 448():437-46. PubMed ID: 18370241 [TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomics in cancer treatment defining genetic bases for inter-individual differences in responses to chemotherapy. Ansari M; Krajinovic M Curr Opin Pediatr; 2007 Feb; 19(1):15-22. PubMed ID: 17224657 [TBL] [Abstract][Full Text] [Related]
5. Cancer pharmacogenomics: achievements in basic research. Nakajima M; Yokoi T Int J Clin Oncol; 2005 Feb; 10(1):14-9. PubMed ID: 15729595 [TBL] [Abstract][Full Text] [Related]
7. Drug methylation in cancer therapy: lessons from the TPMT polymorphism. Krynetski E; Evans WE Oncogene; 2003 Oct; 22(47):7403-13. PubMed ID: 14576848 [TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics of cancer chemotherapy-induced toxicity. Miller CR; McLeod HL J Support Oncol; 2007 Jan; 5(1):9-14. PubMed ID: 17265780 [TBL] [Abstract][Full Text] [Related]
9. Somatic pharmacogenomics in cancer. Ikediobi ON Pharmacogenomics J; 2008 Oct; 8(5):305-14. PubMed ID: 18679398 [TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development. Yan L; Beckman RA Biotechniques; 2005 Oct; 39(4):565-8. PubMed ID: 16235569 [TBL] [Abstract][Full Text] [Related]
11. Cancer pharmacogenomics: international trends. Yamayoshi Y; Iida E; Tanigawara Y Int J Clin Oncol; 2005 Feb; 10(1):5-13. PubMed ID: 15729594 [TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomics. Going from genome to pill. Service RF Science; 2005 Jun; 308(5730):1858-60. PubMed ID: 15976283 [No Abstract] [Full Text] [Related]
13. Cancer pharmacogenomics: progress and obstacles toward the goal. Nishiyama M Int J Clin Oncol; 2005 Feb; 10(1):3-4. PubMed ID: 15729593 [No Abstract] [Full Text] [Related]
14. Pharmacogenetics of cytotoxic drugs. Daly AK; Hall AG Expert Rev Anticancer Ther; 2001 Aug; 1(2):301-8. PubMed ID: 12113035 [TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics and pharmacogenomics: a clinical reality. Ferraldeschi R; Newman WG Ann Clin Biochem; 2011 Sep; 48(Pt 5):410-7. PubMed ID: 21733927 [TBL] [Abstract][Full Text] [Related]
16. [Pharmacogenetics of anticancer drugs]. de Chaisemartin L; Loriot MA Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657 [TBL] [Abstract][Full Text] [Related]
17. Genetic testing in cancer therapeutics. Ezzeldin HH; Diasio RB Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4137-41. PubMed ID: 16857783 [No Abstract] [Full Text] [Related]
18. [Pharmacogenetics and pharmacogenomics of cancers]. Robert J Pathol Biol (Paris); 2004 Jul; 52(6):332-7. PubMed ID: 15261376 [TBL] [Abstract][Full Text] [Related]
19. Cancer pharmacogenomics: do cancer cell lines have the right stuff? Auman JT Pharmacogenomics; 2010 Aug; 11(8):1035-7. PubMed ID: 20712522 [No Abstract] [Full Text] [Related]
20. Pharmacogenomic applications in clinical drug development. Dracopoli NC Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S57-60. PubMed ID: 12856151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]